New advances in the treatment of diabetic kidney disease with non-steroidal corticosteroid receptor antagonist
Diabetic kidney disease(DKD)is a type of kidney disease caused by diabetes mellitus,which seriously affects the quality of life of patients and poses a major burden on the global health economy.Non-steroidal corticosteroid receptor antagonist(MRA)is a novel drug for the treatment of DKD,which has the potential to reduce cardiovascular events and delay the deterioration of renal function.Compared with traditional DKD agents,non-steroidal MRA can more effectively slow down the inflammatory reaction and fibrotic processes,and reduce the incidence of hyperkalemia.This article reviewed the recent progress of non-steroidal MRA's efficacy in DKD,aiming to provide safer and more effective treatment options for DKD patients.
万方数据
